Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 24048523
Cobbold M, et al. (2013) MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Sci Transl Med 5, 203ra125 24048523
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S862-p - ACF7 (human)
Modsite: IVQLkPRsPDHVLKN SwissProt Entrez-Gene
Orthologous residues
ACF7 (human): S862‑p, ACF7 iso2 (human): S862‑p, ACF7 iso3 (human): S827‑p, ACF7 iso5 (human): , ACF7 iso6 (human): , ACF7 (mouse): N862‑p, ACF7 iso4 (mouse): N1013‑p, ACF7 iso7 (mouse): N768‑p, ACF7 (rat): N862‑p, ACF7 iso2 (rat): N862‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, HLA-B*0702 complex

S1876-p - AKAP13 (human)
Modsite: QPKERPRsAVLLVDE SwissProt Entrez-Gene
Orthologous residues
AKAP13 (human): S1876‑p, AKAP13 iso2 (human): S1880‑p, AKAP13 iso4 (human): S1858‑p, AKAP13 (mouse): S1839‑p, AKAP13 (rat): S1838‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S2498-p - AKAP13 (human)
Modsite: QDLRRTEsDSGLKKG SwissProt Entrez-Gene
Orthologous residues
AKAP13 (human): S2498‑p, AKAP13 iso2 (human): S2502‑p, AKAP13 iso4 (human): S2478‑p, AKAP13 (mouse): S2462‑p, AKAP13 (rat): S2446‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, mantle cell lymphoma
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-A*0201 complex, HLA-B*0702 complex

S276-p - AML1 (human)
Modsite: VHPAtPIsPGRASGM SwissProt Entrez-Gene
Orthologous residues
AML1 (human): S276‑p, AML1 iso2 (human): S276‑p, AML1 iso7 (human): , AML1 iso8 (human): S303‑p, AML1 iso10 (human): S291‑p, AML1 (mouse): S276‑p, AML1 (rat): S275‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S1991-p - ANKRD17 (human)
Modsite: STNGSPSsPSVRRQL SwissProt Entrez-Gene
Orthologous residues
ANKRD17 (human): S1991‑p, ANKRD17 iso2 (human): S1990‑p, ANKRD17 (mouse): S1987‑p, ANKRD17 (rat): S1813‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S702-p - ARHGAP17 (human)
Modsite: LsAPRRYsssLsPIQ SwissProt Entrez-Gene
Orthologous residues
ARHGAP17 (human): S702‑p, ARHGAP17 iso2 (human): S624‑p, ARHGAP17 iso5 (human): S702‑p, ARHGAP17 (mouse): S698‑p, ARHGAP17 iso2 (mouse): S620‑p, ARHGAP17 (rat): S710‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S327-p - ARHGAP30 (human)
Modsite: GtLRPAKsMDsLSAA SwissProt Entrez-Gene
Orthologous residues
ARHGAP30 (human): S327‑p, ARHGAP30 iso2 (human): S327‑p, ARHGAP30 iso3 (human): S179‑p, ARHGAP30 (mouse): S328‑p, ARHGAP30 (rat): S328‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, HLA-B*0702 complex

S664-p - ARID1B (human)
Modsite: IQQERPSsLPDLSGS SwissProt Entrez-Gene
Orthologous residues
ARID1B (human): S664‑p, ARID1B iso3 (human): S664‑p, ARID1B (mouse): S619‑p, ARID1B iso5 (mouse): S671‑p, ARID1B (rat): S155‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S692-p - ataxin-2 (human)
Modsite: PKTHRPRsPRQNsIG SwissProt Entrez-Gene
Orthologous residues
ataxin‑2 (human): S692‑p, ataxin‑2 iso2 (human): S692‑p, ataxin‑2 (mouse): S661‑p, ataxin‑2 iso2 (mouse): S591‑p, ataxin‑2 (rat): , ataxin‑2 (cow): S674‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 13; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S496-p - ataxin-2L (human)
Modsite: VGsIsPAsPKIsLAP SwissProt Entrez-Gene
Orthologous residues
ataxin‑2L (human): S496‑p, ataxin‑2L iso2 (human): S496‑p, ataxin‑2L iso3 (human): S496‑p, ataxin‑2L (mouse): S499‑p, ataxin‑2L iso2 (mouse): S493‑p, ataxin‑2L (rat): S493‑p, ataxin‑2L (cow): S497‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, HLA-B*0702 complex

S86-p - Bcl-11A (human)
Modsite: KAVDKPPsPsPIEMK SwissProt Entrez-Gene
Orthologous residues
Bcl‑11A (human): S86‑p, Bcl‑11A iso2 (human): S86‑p, Bcl‑11A iso3 (human): S86‑p, Bcl‑11A (mouse): S86‑p, Bcl‑11A iso13 (mouse): S86‑p, Bcl‑11A (rat): S86‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S775-p - CAF-1A (human)
Modsite: NHtGsPRsPsttyLH SwissProt Entrez-Gene
Orthologous residues
CAF‑1A (human): S775‑p, CAF‑1A iso2 (human): , CAF‑1A iso100 (human): S775‑p, CAF‑1A (mouse):
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S108-p - CapZIP (human)
Modsite: LPGAsPKsPGLKAMV SwissProt Entrez-Gene
Orthologous residues
CapZIP (human): S108‑p, CapZIP (mouse): S108‑p, CapZIP (rat): S78‑p, CapZIP (cow): S108‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, bone marrow, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, HLA-B*0702 complex

S449-p - CCDC45 (human)
Modsite: kPPYRsHsLsPsPVN SwissProt Entrez-Gene
Orthologous residues
CCDC45 (human): S449‑p, CCDC45 (mouse): S447‑p, CCDC45 (rat): S445‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S596-p - CCDC88B (human)
Modsite: PEKAGRRssLQsPAS SwissProt Entrez-Gene
Orthologous residues
CCDC88B (human): S596‑p, CCDC88B iso2 (human): S596‑p, CCDC88B iso5 (human): , CCDC88B (mouse): V601‑p, CCDC88B (rat): V597‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S346-p - CdGAP (human)
Modsite: AtIRPAKsMDsLCSV SwissProt Entrez-Gene
Orthologous residues
CdGAP (human): S346‑p, CdGAP (mouse): S343‑p, CdGAP (rat): S346‑p, CdGAP (cow): S346‑p

S429-p - DMN (human)
Modsite: QTNVRtFsPTyGLLR SwissProt Entrez-Gene
Orthologous residues
DMN (human): S429‑p, DMN iso2 (human): S429‑p, DMN iso3 (human): , DMN (mouse): T430‑p, DMN (rat): I429‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  chronic lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  CLL sample 3; HLA-A*0201 complex, healthy donor 3; HLA-A*0201 complex, healthy donor 5; HLA-A*0201 complex, healthy donor 7; HLA-A*0201 complex

S500-p - ELG (human)
Modsite: RLGKRPHsPEKAFss SwissProt Entrez-Gene
Orthologous residues
ELG (human): S500‑p, ELG iso2 (human): S220‑p, ELG (mouse): S495‑p, ELG (rat): S495‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, HLA-B*0702 complex

S190-p - FAM53C (human)
Modsite: APAHRPYsPPFFSLA SwissProt Entrez-Gene
Orthologous residues
FAM53C (human): S190‑p, FAM53C (mouse): S190‑p, FAM53C (rat): S190‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S20-p - GFI1 (human)
Modsite: HsyHQPRsPGPDYSL SwissProt Entrez-Gene
Orthologous residues
GFI1 (human): S20‑p, GFI1 (mouse): S20‑p, GFI1 (rat): S20‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S56-p - GPSM3 (human)
Modsite: ALGPRsAsLLsLQtE SwissProt Entrez-Gene
Orthologous residues
GPSM3 (human): S56‑p, GPSM3 (mouse): S55‑p, GPSM3 (rat): S54‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S59-p - GPSM3 (human)
Modsite: PRsAsLLsLQtELLL SwissProt Entrez-Gene
Orthologous residues
GPSM3 (human): S59‑p, GPSM3 (mouse): S58‑p, GPSM3 (rat): S57‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S670-p - GRK2 (human)
Modsite: KMKNKPRsPVVELsk SwissProt Entrez-Gene
Orthologous residues
GRK2 (human): S670‑p, GRK2 (mouse): S670‑p, GRK2 (rat): S670‑p, GRK2 (cow): S670‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, HLA-B*0702 complex

S674-p - GTF2I (human)
Modsite: QsPKRPRsPGsNsKV SwissProt Entrez-Gene
Orthologous residues
GTF2I (human): S674‑p, GTF2I iso2 (human): S633‑p, GTF2I iso4 (human): S653‑p, GTF2I (mouse): S674‑p, GTF2I iso8 (mouse): S634‑p, GTF2I (rat): S655‑p, GTF2I iso2 (rat): S589‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S2118-p - HIVEP2 (human)
Modsite: LsPRRPVsPGKDITA SwissProt Entrez-Gene
Orthologous residues
HIVEP2 (human): S2118‑p, HIVEP2 (mouse): S2102‑p, HIVEP2 (rat): S2109‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S21-p - HMGN1 (human)
Modsite: kEEPkRRsARLsAkP SwissProt Entrez-Gene
Orthologous residues
HMGN1 (human): S21‑p, HMGN1 (mouse): S20‑p, HMGN1 (rat): S20‑p, HMGN1 (cow): S21‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S189-p - hnRNP E2 (human)
Modsite: yRPkPsssPVIFAGG SwissProt Entrez-Gene
Orthologous residues
hnRNP E2 (human): S189‑p, hnRNP E2 iso2 (human): S189‑p, hnRNP E2 iso3 (human): S151‑p, hnRNP E2 iso4 (human): S185‑p, hnRNP E2 iso5 (human): S189‑p, hnRNP E2 (mouse): S185‑p, hnRNP E2 iso2 (mouse): S185‑p, hnRNP E2 (rat): S185‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, bone marrow, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, HLA-B*0702 complex

S82-p - HSP27 (human)
Modsite: RALsRQLssGVsEIr SwissProt Entrez-Gene
Orthologous residues
HSP27 (human): S82‑p, HSP27 (mouse): S86‑p, HSP27 (rat): S86‑p, HSP27 (pig): S84‑p, HSP27 (hamster): S90‑p, HSP27 (chicken): S80‑p, HSP27 (dog): S86‑p, HSP27 (cow): S78‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  chronic lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  CLL sample 3; HLA-A*0201 complex, healthy donor 3; HLA-A*0201 complex, healthy donor 7; HLA-A*0201 complex, healthy donor 8; HLA-A*0201 complex

S199-p - IHPK1 (human)
Modsite: LSRMRSEsKDRKLYK SwissProt Entrez-Gene
Orthologous residues
IHPK1 (human): S199‑p, IHPK1 (mouse): S199‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 14; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S1100-p - IRS2 (human)
Modsite: PEAARVAsPTsGVKR SwissProt Entrez-Gene
Orthologous residues
IRS2 (human): S1100‑p, IRS2 (mouse): S1089‑p, IRS2 (rat): S1092‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  chronic lymphocytic leukemia, mantle cell lymphoma
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  CLL sample 1; HLA-A*0201 complex, CLL sample 2; HLA-A*0201 complex, HLA-A*0201 complex

S515-p - KANSL3 (human)
Modsite: ERGsRPAsPAAKLPA SwissProt Entrez-Gene
Orthologous residues
KANSL3 (human): S515‑p, KANSL3 iso2 (human): S515‑p, KANSL3 iso3 (human): S515‑p, KANSL3 (mouse): S515‑p, KANSL3 iso2 (mouse): S515‑p, KANSL3 (rat): S515‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

T66-p - KLF10 (human)
Modsite: YVENRPVtPVSDLSE SwissProt Entrez-Gene
Orthologous residues
KLF10 (human): T66‑p, KLF10 iso2 (human): T55‑p, KLF10 (mouse): T65‑p, KLF10 iso3 (mouse): T66‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, HLA-B*0702 complex

T173-p - KLF2 (human)
Modsite: RPPPPPDtPPLsPDG SwissProt Entrez-Gene
Orthologous residues
KLF2 (human): T173‑p, KLF2 (mouse): T171‑p, KLF2 (rat): T171‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 17; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S116-p - LPP (human)
Modsite: tLEERRSsLDAEIDS SwissProt Entrez-Gene
Orthologous residues
LPP (human): S116‑p, LPP (mouse): S117‑p, LPP (rat): S117‑p, LPP (cow): S116‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

T175-p - LSP1 (human)
Modsite: QKCQQPRtPsPLVLE SwissProt Entrez-Gene
Orthologous residues
LSP1 (human): T175‑p, LSP1 iso2 (human): T113‑p, LSP1 iso3 (human): T303‑p, LSP1 (mouse): T166‑p, LSP1 iso3 (mouse): T158‑p, LSP1 (rat): T167‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S177-p - LSP1 (human)
Modsite: CQQPRtPsPLVLEGt SwissProt Entrez-Gene
Orthologous residues
LSP1 (human): S177‑p, LSP1 iso2 (human): S115‑p, LSP1 iso3 (human): S305‑p, LSP1 (mouse): S168‑p, LSP1 iso3 (mouse): S160‑p, LSP1 (rat): S169‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S204-p - LSP1 (human)
Modsite: KLIDRtEsLNRsIEK SwissProt Entrez-Gene
Orthologous residues
LSP1 (human): S204‑p, LSP1 iso2 (human): S142‑p, LSP1 iso3 (human): S332‑p, LSP1 (mouse): S195‑p, LSP1 iso3 (mouse): S187‑p, LSP1 (rat): S196‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  chronic lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 1; HLA-A*0201 complex, CLL sample 2; HLA-A*0201 complex, CLL sample 3; HLA-A*0201 complex, CLL sample 4; HLA-A*0201 complex, healthy donor 8; HLA-A*0201 complex, HLA-A*0201 complex

S252-p - LSP1 (human)
Modsite: PKLARQAsIELPsMA SwissProt Entrez-Gene
Orthologous residues
LSP1 (human): S252‑p, LSP1 iso2 (human): S190‑p, LSP1 iso3 (human): S380‑p, LSP1 (mouse): S243‑p, LSP1 iso3 (mouse): S235‑p, LSP1 (rat): S244‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia, chronic lymphocytic leukemia, mantle cell lymphoma
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 1; HLA-A*0201 complex, CLL sample 2; HLA-A*0201 complex, CLL sample 3; HLA-A*0201 complex, CLL sample 4; HLA-A*0201 complex, healthy donor 3; HLA-A*0201 complex, healthy donor 7; HLA-A*0201 complex, healthy donor 8; HLA-A*0201 complex, HLA-A*0201 complex

S745-p - LUZP1 (human)
Modsite: VKSQRPFsPREALRS SwissProt Entrez-Gene
Orthologous residues
LUZP1 (human): S745‑p, LUZP1 iso2 (human): S745‑p, LUZP1 iso3 (human): S745‑p, LUZP1 (mouse): S746‑p, LUZP1 iso1 (mouse): S384‑p, LUZP1 (rat): S746‑p, LUZP1 (cow): S744‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, HLA-B*0702 complex

S2617-p - MAP1A (human)
Modsite: PGkAkPAsPARRLDL SwissProt Entrez-Gene
Orthologous residues
MAP1A (human): S2617‑p, MAP1A iso2 (human): S2617‑p, MAP1A (mouse): S2591‑p, MAP1A (rat): S2588‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S201-p - MEF2D (human)
Modsite: GLPQRPAsAGAMLGG SwissProt Entrez-Gene
Orthologous residues
MEF2D (human): S201‑p, MEF2D iso2 (human): S200‑p, MEF2D iso4 (human): S201‑p, MEF2D (mouse): S201‑p, MEF2D iso2 (mouse): S208‑p, MEF2D (rat): S201‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, bone marrow, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 11; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, HLA-B*0702 complex

S1018-p - mGluR5 (human)
Modsite: PAPARPRsPsPISTL SwissProt Entrez-Gene
Orthologous residues
mGluR5 (human): S1018‑p, mGluR5 (mouse): S1014‑p, mGluR5 (rat): S1014‑p, mGluR5 iso2 (rat): S982‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S113-p - MIIP (human)
Modsite: LGRPRPHsAPSLGTS SwissProt Entrez-Gene
Orthologous residues
MIIP (human): S113‑p, MIIP (mouse): S120‑p, MIIP (rat): S121‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S758-p - MLK3 (human)
Modsite: GtPGtPRsPPLGLIS SwissProt Entrez-Gene
Orthologous residues
MLK3 (human): S758‑p, MLK3 (mouse): S761‑p, MLK3 (rat): S761‑p, MLK3 (cow): S775‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 11; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S161-p - MLL (human)
Modsite: DEEVRVRsPtRsPsV SwissProt Entrez-Gene
Orthologous residues
MLL (human): S161‑p, MLL iso2 (human): S161‑p, MLL iso3 (human): S161‑p, MLL (mouse): S159‑p, MLL iso5 (mouse): S192‑p, MLL (rat):
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S750-p - MLL (human)
Modsite: PIRsEPRsPsHsMRT SwissProt Entrez-Gene
Orthologous residues
MLL (human): S750‑p, MLL iso2 (human): S750‑p, MLL iso3 (human): S750‑p, MLL (mouse): S748‑p, MLL iso5 (mouse): S781‑p, MLL (rat): S488‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S856-p - MORC2 (human)
Modsite: VRLMKPPsPEHQsLD SwissProt Entrez-Gene
Orthologous residues
MORC2 (human): S856‑p, MORC2 iso2 (human): S794‑p, MORC2 (mouse): S854‑p, MORC2 iso2 (mouse): S793‑p, MORC2 (rat): S805‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

T19-p - MRLC1 (human)
Modsite: KKRPQRAtsNVFAMF SwissProt Entrez-Gene
Orthologous residues
MRLC1 (human): T19‑p, MRLC1 (mouse): T19‑p, MRLC1 (rat): T19‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S20-p - MRLC1 (human)
Modsite: KRPQRAtsNVFAMFD SwissProt Entrez-Gene
Orthologous residues
MRLC1 (human): S20‑p, MRLC1 (mouse): S20‑p, MRLC1 (rat): S20‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

T19-p - MRLC2 (human)
Modsite: KKRPQRAtsNVFAMF SwissProt Entrez-Gene
Orthologous residues
MRLC2 (human): T19‑p, MRLC2 (mouse): T19‑p, MRLC2 (rat): T19‑p, MRLC2 (cow): T19‑p

S20-p - MRLC2 (human)
Modsite: KRPQRAtsNVFAMFD SwissProt Entrez-Gene
Orthologous residues
MRLC2 (human): S20‑p, MRLC2 (mouse): S20‑p, MRLC2 (rat): S20‑p, MRLC2 (cow): S20‑p

T18-p - MRLC3 (human)
Modsite: KKRPQRAtsNVFAMF SwissProt Entrez-Gene
Orthologous residues
MRLC3 (human): T18‑p, MRLC3 (mouse): T19‑p, MRLC3 (rat): T19‑p

S19-p - MRLC3 (human)
Modsite: KRPQRAtsNVFAMFD SwissProt Entrez-Gene
Orthologous residues
MRLC3 (human): S19‑p, MRLC3 (mouse): S20‑p, MRLC3 (rat): S20‑p

S293-p - Myc (human)
Modsite: GHskPPHsPLVLkRC SwissProt Entrez-Gene
Orthologous residues
Myc (human): S293‑p, Myc iso2 (human): S308‑p, Myc (mouse): S293‑p, Myc (rat): S293‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S132-p - Nedd4-BP2 (human)
Modsite: SEDSKMDsFLDMQLT SwissProt Entrez-Gene
Orthologous residues
Nedd4‑BP2 (human): S132‑p, Nedd4‑BP2 (mouse): S67‑p, Nedd4‑BP2 (rat): S133‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  chronic lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 4; HLA-A*0201 complex, healthy donor 8; HLA-A*0201 complex, HLA-A*0201 complex

S73-p - NFAT1 (human)
Modsite: DYGLkPysPLASLsG SwissProt Entrez-Gene
Orthologous residues
NFAT1 (human): S73‑p, NFAT1 iso2 (human): S73‑p, NFAT1 iso3 (human): S53‑p, NFAT1 (mouse): N73‑p, NFAT1 iso2 (mouse): N53‑p, NFAT1 (rat): N73‑p, NFAT1 (chicken): P80‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, HLA-B*0702 complex

S247-p - NIFK (human)
Modsite: tFLERRKsQVAELND SwissProt Entrez-Gene
Orthologous residues
NIFK (human): S247‑p, NIFK (mouse): S270‑p, NIFK (rat): S226‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S20-p - NSBP1 (human)
Modsite: RQEPKRRsARLsAML SwissProt Entrez-Gene
Orthologous residues
NSBP1 (human): S20‑p, NSBP1 (mouse): S18‑p, NSBP1 (rat): S18‑p

S19-p - p300 (human)
Modsite: sAkRPKLsSPALSAS SwissProt Entrez-Gene
Orthologous residues
p300 (human): S19‑p, p300 (mouse): S19‑p, p300 (rat): S19‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 17; HLA-B*0702 complex, HLA-B*0702 complex

T320-p - PPP1CA (human)
Modsite: NPGGRPItPPRNsAK SwissProt Entrez-Gene
Orthologous residues
PPP1CA (human): T320‑p, PPP1CA iso2 (human): T331‑p, PPP1CA (mouse): T320‑p, PPP1CA (rat): T320‑p, PPP1CA (rabbit): T320‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 12; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S242-p - pyrin (human)
Modsite: SGKMRPRsLEVTIST SwissProt Entrez-Gene
Orthologous residues
pyrin (human): S242‑p, pyrin (mouse): S241‑p, pyrin (rat): V240‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S627-p - RBM14 (human)
Modsite: sQLsFRRsPtKssLD SwissProt Entrez-Gene
Orthologous residues
RBM14 (human): S627‑p, RBM14 (mouse): S627‑p, RBM14 (rat): S627‑p, RBM14 (cow): S627‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S294-p - RBM15 (human)
Modsite: GGGQRsLsPGGAALG SwissProt Entrez-Gene
Orthologous residues
RBM15 (human): S294‑p, RBM15 iso2 (human): S294‑p, RBM15 iso3 (human): S294‑p, RBM15 (mouse): S293‑p, RBM15 (rat): S293‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S222-p - RBM17 (human)
Modsite: EEQDRPRsPtGPsNs SwissProt Entrez-Gene
Orthologous residues
RBM17 (human): S222‑p, RBM17 (mouse): S222‑p, RBM17 (rat): S222‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S479-p - RERE (human)
Modsite: NtPSRPPsSEFLDLS SwissProt Entrez-Gene
Orthologous residues
RERE (human): S479‑p, RERE (mouse): S479‑p, RERE (rat): S478‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 11; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, HLA-B*0702 complex

S446-p - RPRC1 (human)
Modsite: kRQsLPAsPRARLsA SwissProt Entrez-Gene
Orthologous residues
RPRC1 (human): S446‑p, RPRC1 iso2 (human): S409‑p, RPRC1 iso4 (human): S414‑p, RPRC1 (mouse): S448‑p, RPRC1 (rat): S416‑p, RPRC1 (cow): S448‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S1167-p - RREB1 (human)
Modsite: RsRPRANsGGVDLDs SwissProt Entrez-Gene
Orthologous residues
RREB1 (human): S1167‑p, RREB1 iso2 (human): S1167‑p, RREB1 (mouse): S1172‑p, RREB1 (rat): S1170‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S27-p - RSRP1 (human)
Modsite: sTSRsGGssRLSSRS SwissProt Entrez-Gene
Orthologous residues
RSRP1 (human): S27‑p, RSRP1 (mouse): S32‑p, RSRP1 (rat): S32‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S937-p - SCAP (human)
Modsite: TPALRPPsPGPVLsQ SwissProt Entrez-Gene
Orthologous residues
SCAP (human): S937‑p, SCAP (mouse): S934‑p, SCAP (rat): S934‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 11; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, healthy donor 20; HLA-B*0702 complex, HLA-B*0702 complex

S1228-p - SETD2 (human)
Modsite: TFQNRPDsRLGKTEL SwissProt Entrez-Gene
Orthologous residues
SETD2 (human): S1228‑p, SETD2 (mouse): S1200‑p, SETD2 (rat): S957‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, healthy donor 15; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S163-p - SFRS7 (human)
Modsite: RsAsPRRsRsIsLRR SwissProt Entrez-Gene
Orthologous residues
SFRS7 (human): S163‑p, SFRS7 iso2 (human): , SFRS7 iso4 (human): , SFRS7 (mouse): S192‑p, SFRS7 iso2 (mouse): S163‑p, SFRS7 (rat): S163‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 12; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, HLA-B*0702 complex

T1737-p - SHARP (human)
Modsite: YLDAKPPtPGASFSQ SwissProt Entrez-Gene
Orthologous residues
SHARP (human): T1737‑p, SHARP (mouse): T1755‑p, SHARP (rat): T1732‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 12; HLA-B*0702 complex, HLA-B*0702 complex

S435-p - SIK (human)
Modsite: VFRPRPVsPsSLLDT SwissProt Entrez-Gene
Orthologous residues
SIK (human): S435‑p, SIK (mouse): S437‑p, SIK (rat): S437‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 12; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, HLA-B*0702 complex

S383-p - SKI (human)
Modsite: LsAFRPWsPAVSASE SwissProt Entrez-Gene
Orthologous residues
SKI (human): S383‑p, SKI (mouse): S380‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 14; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S2413-p - SMRT (human)
Modsite: PsSRKAKsPAPGLAs SwissProt Entrez-Gene
Orthologous residues
SMRT (human): S2413‑p, SMRT iso2 (human): S665‑p, SMRT iso4 (human): S2396‑p, SMRT iso5 (human): S2350‑p, SMRT (mouse): S2371‑p, SMRT iso4 (mouse): S2231‑p, SMRT (rat): S2371‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  chronic lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-A*0201 complex, healthy donor 7; HLA-A*0201 complex, healthy donor 8; HLA-A*0201 complex

S1122-p - SOGA1 (human)
Modsite: RQAMRsGsLERKVkS SwissProt Entrez-Gene
Orthologous residues
SOGA1 (human): S1122‑p, SOGA1 iso2 (human): S1360‑p, SOGA1 iso3 (human): S251‑p, SOGA1 (mouse): S1119‑p, SOGA1 iso2 (mouse): S1355‑p, SOGA1 (rat): S1254‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 13; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, HLA-B*0702 complex

S2013-p - SON (human)
Modsite: RRRsFsIsPVRLRRs SwissProt Entrez-Gene
Orthologous residues
SON (human): S2013‑p, SON iso3 (human): S2013‑p, SON iso5 (human): S2013‑p, SON iso9 (human): S2053‑p, SON iso10 (human): S2013‑p, SON (mouse): S2031‑p, SON (rat): S2033‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 12; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S863-p - SRC-1 (human)
Modsite: SATARPTsRLNRLPE SwissProt Entrez-Gene
Orthologous residues
SRC‑1 (human): S863‑p, SRC‑1 iso2 (human): S863‑p, SRC‑1 (mouse): P869‑p, SRC‑1 (rat): P804‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 11; HLA-B*0702 complex, healthy donor 12; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S2426-p - SRm300 (human)
Modsite: MTsERAPsPssRMGQ SwissProt Entrez-Gene
Orthologous residues
SRm300 (human): S2426‑p, SRm300 iso2 (human): , SRm300 (mouse): S2381‑p, SRm300 iso2 (mouse): S2285‑p, SRm300 iso3 (mouse): S2381‑p, SRm300 (rat): S2384‑p, SRm300 (cow): S2400‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 11; HLA-B*0702 complex, healthy donor 14; HLA-B*0702 complex, healthy donor 18; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S252-p - SRp46 (human)
Modsite: RSSSMtRsPPRVSKR SwissProt Entrez-Gene
Orthologous residues
SRp46 (human): S252‑p, SRp46 iso2 (human): S245‑p, SRp46 iso3 (human): S518‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  chronic lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  CLL sample 3; HLA-A*0201 complex, healthy donor 3; HLA-A*0201 complex, healthy donor 5; HLA-A*0201 complex, healthy donor 7; HLA-A*0201 complex, healthy donor 8; HLA-A*0201 complex

S245-p - supervillin (human)
Modsite: sFtEVPRsPKHAHSS SwissProt Entrez-Gene
Orthologous residues
supervillin (human): S245‑p, supervillin iso2 (human): S245‑p, supervillin iso3 (human): S245‑p, supervillin iso4 (human): S245‑p, supervillin (mouse): S227‑p, supervillin iso4 (mouse): S227‑p, supervillin (rat): S226‑p, supervillin (ferret): S231‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S864-p - SYNPO (human)
Modsite: LPRPSRssPGLyTsP SwissProt Entrez-Gene
Orthologous residues
SYNPO (human): S864‑p, SYNPO iso2 (human): S620‑p, SYNPO (mouse): S864‑p, SYNPO iso2 (mouse): S625‑p, SYNPO (rat): S866‑p, SYNPO iso2 (rat): S627‑p, SYNPO iso4 (rat): S627‑p, SYNPO (cow):
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

T415-p - TBC1D10C (human)
Modsite: KPQTRGktFHGLLTR SwissProt Entrez-Gene
Orthologous residues
TBC1D10C (human): T415‑p, TBC1D10C (mouse): T413‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 13; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, HLA-B*0702 complex

S1441-p - tensin 3 (human)
Modsite: VSKVMIGsPKKV___ SwissProt Entrez-Gene
Orthologous residues
tensin 3 (human): S1441‑p, tensin 3 iso2 (human): S1201‑p, tensin 3 (mouse): S1436‑p, tensin 3 (rat): S1440‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  mantle cell lymphoma
Relevant cell lines - cell types - tissues:  blood, mononuclear-blood
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 3; HLA-A*0201 complex, healthy donor 8; HLA-A*0201 complex, HLA-A*0201 complex

S188-p - TLK1 (human)
Modsite: SSSVRPNsPSPtALA SwissProt Entrez-Gene
Orthologous residues
TLK1 (human): S188‑p, TLK1 iso2 (human): S209‑p, TLK1 iso4 (human): S92‑p, TLK1 (mouse): S188‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, JY (lymphoblastoid), mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 13; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, HLA-B*0702 complex

S139-p - TNRC15 (human)
Modsite: ECGFYQRsFDEVEGV SwissProt Entrez-Gene
Orthologous residues
TNRC15 (human): S139‑p, TNRC15 iso3 (human): S139‑p, TNRC15 iso4 (human): S139‑p, TNRC15 (mouse): S140‑p, TNRC15 iso3 (mouse):
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S121-p - TPX2 (human)
Modsite: PAQPQRRsLRLsAQk SwissProt Entrez-Gene
Orthologous residues
TPX2 (human): S121‑p, TPX2 iso2 (human): S121‑p, TPX2 (mouse): S121‑p, TPX2 (rat): S121‑p, TPX2 (frog): S86‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  healthy donor 14; HLA-B*0702 complex, HLA-B*0702 complex

S263-p - TSC22D4 (human)
Modsite: PPLDsRPssPALYFt SwissProt Entrez-Gene
Orthologous residues
TSC22D4 (human): S263‑p, TSC22D4 (mouse): N257‑p, TSC22D4 iso3 (mouse): , TSC22D4 (rat): N257‑p, TSC22D4 (cow): S283‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, hairy cell leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid), mononuclear-blood
Cellular systems studied:  cell lines, primary cells, tissue
Species studied:  human
Comments:  CLL sample 2; HLA-B*0702 complex, CLL sample 4; HLA-B*0702 complex, healthy donor 16; HLA-B*0702 complex, HLA-B*0702 complex

S3319-p - VPS13D (human)
Modsite: HELARSLsPLLFCYA SwissProt Entrez-Gene
Orthologous residues
VPS13D (human): S3319‑p, VPS13D (mouse): S3289‑p, VPS13D (rat): S3304‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry
Disease tissue studied:  acute lymphocytic leukemia
Relevant cell lines - cell types - tissues:  B lymphocyte-spleen, blood, mononuclear-blood, T lymphocyte-spleen
Cellular systems studied:  primary cells, tissue
Species studied:  human
Comments:  healthy donor 16; HLA-B*0702 complex, healthy donor 17; HLA-B*0702 complex, healthy donor 19; HLA-B*0702 complex, HLA-B*0702 complex

S515-p - ZC3H14 (human)
Modsite: VQPDkPAsPKFIVTL SwissProt Entrez-Gene
Orthologous residues
ZC3H14 (human): S515‑p, ZC3H14 iso2 (human): S515‑p, ZC3H14 iso3 (human): , ZC3H14 iso4 (human): , ZC3H14 iso5 (human): S490‑p, ZC3H14 iso6 (human): , ZC3H14 iso9 (human): S515‑p, ZC3H14 (mouse): S515‑p, ZC3H14 (rat): S515‑p, ZC3H14 (cow): S515‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood, JY (lymphoblastoid)
Cellular systems studied:  cell lines, tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S859-p - ZFP106 (human)
Modsite: PGLARKRsLsEssVI SwissProt Entrez-Gene
Orthologous residues
ZFP106 (human): S859‑p, ZFP106 iso2 (human): S87‑p, ZFP106 (mouse): S876‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex

S114-p - ZNF219 (human)
Modsite: HQPERPRsPAARLLL SwissProt Entrez-Gene
Orthologous residues
ZNF219 (human): S114‑p, ZNF219 (mouse): S118‑p, ZNF219 (rat): S118‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  acute myelogenous leukemia
Relevant cell lines - cell types - tissues:  blood
Cellular systems studied:  tissue
Species studied:  human
Comments:  HLA-B*0702 complex